Arrowhead Business and Investment Decisions's posts
Post has attachment
Hybrigenics SA | abid
Hybrigenics is a bio-pharmaceutical group listed (ALHYG) on the Alternext market of Euronext Paris, focusing its internal R&D programs on innovative targets and therapies for the treatment of proliferative diseases. Hybrigenics' development program is based on inecalcitol, a vitamin D receptor agonist.
one plus one
Wait while more posts are being loaded